Haynes Boone advised ASP Isotopes Inc. (NASDAQ: ASPI) in connection with a transformative private placement and reverse merger that is expected to establish Noble Africa Inc. as a Nasdaq-listed company focused on advancing Renergen's Virginia Gas Project in South Africa.
Under the terms of the transaction, ASP Isotopes' wholly owned subsidiary, Noble Africa LLC, an intermediate holding company for Renergen Limited, will merge with a subsidiary of ENDRA Life Sciences Inc. (NASDAQ: NDRA). Upon closing, the combined company will operate as Noble Africa Inc. and is expected to trade on Nasdaq.
Concurrently, Noble Africa secured commitments for an approximately $50 million private placement financing, including funds invested by ASP Isotopes, intended to support the development of Phase 1 and Phase 2 of Renergen’s Virginia Gas Project.
Haynes Boone's deal team was led by Capital Markets Partners Matt Fry and Rachel O'Donnell and M&A Partner Simin Sun, with support from Associates Brent Duddles, Alexandria Pencsak and Lisa Vasek. The deal team was supported by a wider multidisciplinary group of Haynes Boone attorneys.
"We were pleased to help ASP Isotopes navigate the complexities of a cross-border reverse merger and related financing to position Noble Africa for a public listing," said Fry.
Haynes Boone’s Capital Markets Practice advises on high-value public offerings, including IPOs, PIPEs, reverse mergers and dual listings. The team has led landmark deals across energy, tech, life sciences and financial services, including one of the largest IPOs in LSE history and the first Nasdaq-LSE dual listing of this century. Clients rely on the firm’s cross-border experience and integrated counsel across major U.S., U.K. and global exchanges for securities transactions, compliance and REIT structuring.
